Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology · 2026
[A case where phenobarbital was remarkably effective against drug-induced liver injury presenting with prolonged intrahepatic cholestasis caused by Ashwagandha].
СтатьяКлинический случайАннотация на английскомНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hashimoto Hideatsu, Watanabe Tsunamasa, Suzuki Tatsuya, Ando Yuwa, Ehira Takuya, Kanazawa Minoru, Koizumi Hirotaka, Koike Junki, Tateishi Keisuke
Аннотация
This case concerns a 39-year-old male with a history of adjustment disorder, and he had been using Ashwagandha-self-prescribed and self-imported online-for stress relief and vitality enhancement for the past 3 months. He visited the emergency department with symptoms of hyperventilation, and blood tests showed total bilirubin of 2.37mg/dL, ALT of 384U/L, and ALP of 92U/L, indicating hepatocellular-type liver dysfunction, thereby raising suspicion for drug-induced liver injury (DILI). Although ursodeoxycholic acid was initiated after referring to our hospital, his condition showed minimal improvement. A liver biopsy showed no infiltration of inflammatory cells, no dilation of the bile ducts, and no bile plugs, ruling out bile outflow obstruction. However, bilirubin deposition within hepatocytes and hepatocellular degeneration were noted. With a suspected defect in the hepatocellular bile transport, phenobarbital was started, resulting in rapid improvement of jaundice. Reports of DILI caused by Ashwagandha are rare, and this case exhibited clinical findings and test results different from those previously reported.